Your browser doesn't support javascript.
loading
Once-weekly subcutaneous semaglutide treatment for persons with type 2 diabetes: Real-world data from a diabetes out-patient clinic.
Hansen, Katrine B; Svendstrup, Mathilde; Lund, Asger; Knop, Filip K; Vilsbøll, Tina; Vestergaard, Henrik.
Affiliation
  • Hansen KB; Steno Diabetes Center Copenhagen, Gentofte, Denmark.
  • Svendstrup M; Steno Diabetes Center Copenhagen, Gentofte, Denmark.
  • Lund A; Steno Diabetes Center Copenhagen, Gentofte, Denmark.
  • Knop FK; Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
  • Vilsbøll T; Steno Diabetes Center Copenhagen, Gentofte, Denmark.
  • Vestergaard H; Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
Diabet Med ; 38(10): e14655, 2021 10.
Article in En | MEDLINE | ID: mdl-34291491
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Glucagon-Like Peptides Type of study: Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Diabet Med Journal subject: ENDOCRINOLOGIA Year: 2021 Document type: Article Affiliation country: Denmark Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Glucagon-Like Peptides Type of study: Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Diabet Med Journal subject: ENDOCRINOLOGIA Year: 2021 Document type: Article Affiliation country: Denmark Country of publication: United kingdom